Log in

Relevant bibliographies by topics / Nis / Journal articles

To see the other types of publications on this topic, follow the link: Nis.

Journal articles on the topic 'Nis'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Nis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ramzan, Maryam, Mohsin Javed, Shahid Iqbal, et al. "Designing Highly Active S-g-C3N4/Te@NiS Ternary Nanocomposites for Antimicrobial Performance, Degradation of Organic Pollutants, and Their Kinetic Study." Inorganics 11, no. 4 (2023): 156. http://dx.doi.org/10.3390/inorganics11040156.

Full text

Abstract:

The current research is about the synthesis of pure nickel sulfide, a series of Te (0, 0.5, 1, 1.5, 2, and 3 wt.%)-doped NiS (Te@NiS) nanoparticles (NPs), and a series of S-g-C3N4 (10, 30, 50, 70, and 80 wt.%)/Te@NiS nanocomposites (NCs), fabricated through a hydrothermal route. XRD and FTIR spectroscopic techniques demonstrated the successful synthesis of NPs and NCs. SEM-EDX images confirmed the flakelike structure and elemental constituents of the fabricated materials. Tauc plots were drawn, to calculate the band gaps of the synthesized samples. Te doping resulted in a significant reduction

APA, Harvard, Vancouver, ISO, and other styles

2

OSHIMA, Chisei. "nis-kray^i:." Journal of Indian and Buddhist Studies (Indogaku Bukkyogaku Kenkyu) 60, no. 3 (2012): 1125–31. http://dx.doi.org/10.4259/ibk.60.3_1125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hsieh, Ruey-Yu, I.-Chen Huang, Chiehfeng Chen, and Jia-Ying Sung. "Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review." Nutrients 15, no. 16 (2023): 3634. http://dx.doi.org/10.3390/nu15163634.

Full text

Abstract:

Alpha-lipoic acid (ALA) was found to improve the symptoms in patients with diabetic sensorimotor peripheral neuropathy (DSPN) by reducing oxidative stress and ameliorating microcirculation. Our meta-analysis is aimed at evaluating the effects of oral-administered ALA versus a placebo in patients with DSPN and determining the optimal dosage for this treatment. We systematically reviewed randomized controlled trials (RCTs) in the PubMed, Embase, and Cochrane databases to determine the efficacy of oral ALA for patients with DSPN. The primary outcome was total symptoms’ score (TSS), and secondary

APA, Harvard, Vancouver, ISO, and other styles

4

Zou, Long, Lei Wang, Li Sun, Xiaofei Xie, and Pinhua Li. "Photo-driven haloazidation cyclization of 1,5-enynes having cyano groups with TMSN3 and NIS/NCS/NBS under metal-free conditions." Chemical Communications 56, no. 57 (2020): 7933–36. http://dx.doi.org/10.1039/d0cc02471f.

Full text

Abstract:

A visible-light-driven three-component haloazidation cyclization of 1,5-enynes having cyano groups with TMSN<sub>3</sub> and N-iodo(bromo/chloro)succinimide (NIS/NCS/NBS) under metal-free conditions was developed.

APA, Harvard, Vancouver, ISO, and other styles

5

Sniady, Adam. "N-Iodosuccinimide (NIS)." Synlett 2006, no. 06 (2006): 960–61. http://dx.doi.org/10.1055/s-2006-939055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Pekola, J. P., J. M. Kyynäräinen, M. M. Leivo, and A. J. Manninen. "NIS chip refrigeration." Cryogenics 39, no. 8 (1999): 653–57. http://dx.doi.org/10.1016/s0011-2275(99)00064-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Morton, J. M., J. A. Galanko, N. J. Soper, D. E. Low, J. Hunter, and L. W. Traverso. "NIS vs SAGES." Surgical Endoscopy 20, no. 7 (2006): 1124–28. http://dx.doi.org/10.1007/s00464-004-8829-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sowa, Heidrun, Helmut Klein, and Lars Raue. "Determination of the Orientation Relations between the Low- and High-Temperature Phases of NiS." Solid State Phenomena 160 (February 2010): 177–82. http://dx.doi.org/10.4028/www.scientific.net/ssp.160.177.

Full text

Abstract:

In order to get information about the transition mechanism, the temperature-induced transformation in the binary com¬pound NiS was investigated. Above 379 °C, a single crystal of millerite -NiS transforms to polycrystalline NiAs type -NiS with a sharp texture. Pole figures of both phases in the same orientation were measured using synchrotron radiation and an imaging plate detector. The Rietveld texture analysis showed that there are at least three components of the high-temperature -NiS phase. The main component shows the following orientation relations: [001]NiAs type  [001]millerite, [

APA, Harvard, Vancouver, ISO, and other styles

9

Arivazhagan, Mani, Yesupatham Manova Santhosh, and Govindhan Maduraiveeran. "Non-Enzymatic Glucose Detection Based on NiS Nanoclusters@NiS Nanosphere in Human Serum and Urine." Micromachines 12, no. 4 (2021): 403. http://dx.doi.org/10.3390/mi12040403.

Full text

Abstract:

Herein, we report a non-enzymatic electrochemical glucose sensing platform based on NiS nanoclusters dispersed on NiS nanosphere (NC-NiS@NS-NiS) in human serum and urine samples. The NC-NiS@NS-NiS are directly grown on nickel foam (NF) (NC-NiS@NS-NiS|NF) substrate by a facile, and one-step electrodeposition strategy under acidic solution. The as-developed nanostructured NC-NiS@NS-NiS|NF electrode materials successfully employ as the enzyme-mimic electrocatalysts toward the improved electrocatalytic glucose oxidation and sensitive glucose sensing. The NC-NiS@NS-NiS|NF electrode presents an outs

APA, Harvard, Vancouver, ISO, and other styles

10

Zhang, Zongjing, Dingxie Liu, Avaniyapuram Kannan Murugan, Zhimin Liu, and Mingzhao Xing. "Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer." Endocrine-Related Cancer 21, no. 2 (2013): 161–73. http://dx.doi.org/10.1530/erc-13-0399.

Full text

Abstract:

The BRAF V600E mutation causes impaired expression of sodium iodide symporter (NIS) and radioiodine refractoriness of thyroid cancer, but the underlying mechanism remains undefined. In this study, we hypothesized that histone deacetylation at the NIS (SLC5A5) promoter was the mechanism. Using the chromatin immunoprecipitation approach, we examined histone acetylation status on the lysine residues H3K9/14, H3K18, total H4, and H4K16 at the NIS promoter under the influence of BRAF V600E. We found that expression of stably or transiently transfected BRAF V600E inhibited NIS expression while the d

APA, Harvard, Vancouver, ISO, and other styles

11

Santibanez, Tammy A., Anup Srivastav, Yusheng Zhai, and James A. Singleton. "Trends in Childhood Influenza Vaccination Coverage, United States, 2012-2019." Public Health Reports 135, no. 5 (2020): 640–49. http://dx.doi.org/10.1177/0033354920944867.

Full text

Abstract:

Objective The objective was to compare estimates of childhood influenza vaccination across 7 consecutive influenza seasons based on 2 survey systems. Methods We analyzed data from the National Health Interview Survey (NHIS) and the National Immunization Survey–Flu (NIS-Flu) using Kaplan-Meier survival analysis to estimate receipt, based on parental report, of at least 1 dose of influenza vaccine among children aged 6 months to 17 years. Results We found no significant increasing trend in influenza vaccination coverage among children overall from 2012 to 2018 based on the NHIS or from 2012 to 2

APA, Harvard, Vancouver, ISO, and other styles

12

Baines, Darrin. "From the NIS to the NHS via the Floating Sixpence." Prescriber 24, no. 19 (2013): 47–49. http://dx.doi.org/10.1002/psb.1115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Dalheim, Advokat Tron, Seniorrådgiver Anders Østre, and Advokat Tonje Urdal Sand. "Sjømannsloven og NIS-loven." Arbeidsrett 5, no. 02 (2008): 95–113. http://dx.doi.org/10.18261/issn1504-3088-2008-02-03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Stojancov, Simonida Seskar, and Slobodanka Milicevic Misic. "Benzodiazepen poisoning in Nis." Toxicology Letters 180 (October 2008): S139. http://dx.doi.org/10.1016/j.toxlet.2008.06.782.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Wolff, J. "A Miss for NIS?" Thyroid 12, no. 4 (2002): 295–97. http://dx.doi.org/10.1089/10507250252949414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Chen, Peng, and You Wei Du. "Giant Magnetoresistance in NiS." Journal of the Physical Society of Japan 70, no. 1 (2001): 209–11. http://dx.doi.org/10.1143/jpsj.70.209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Burgstaller, Peter. "NIS – Netz- und Informationssicherheit." Zeitschrift für Informationsrecht, no. 2 (2016): 139–46. http://dx.doi.org/10.33196/ziir201602013901.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Liu, Shuling, Qiangqiang Shi, Jianbo Tong, Shu Li та Miaomiao Li. "Controlled synthesis of spherical α-NiS and urchin-like β-NiS microstructures". Journal of Experimental Nanoscience 9, № 5 (2012): 475–81. http://dx.doi.org/10.1080/17458080.2012.669853.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Zenetos, Argyro, Alper Doğan, Ahmet Kerem Bakir, et al. "Non-Indigenous Species (NIS) Know No Geopolitical Borders—An Update of NIS in the Aegean Sea." Diversity 17, no. 1 (2024): 12. https://doi.org/10.3390/d17010012.

Full text

Abstract:

In this work, combined efforts by Greek and Turkish scientists produced an updated validated NIS inventory of the Aegean ecoregion, covering 120 years of records up to August 2024. Of the 342 NIS currently present in the Aegean Sea, the majority (281 species) have invaded the South Aegean, followed by the North Aegean (128 species out of 206 NIS). A total of 73 species were added to the list, while 56 were removed. Overall, unaided spread of Lessepsian immigrants from the Levantine Sea and shipping are equally responsible for NIS reported at the regional level. An increase in publications addr

APA, Harvard, Vancouver, ISO, and other styles

20

Wu, Dan, Xiubo Xie, Jingjing Zhang, et al. "Embedding NiS nanoflakes in electrospun carbon fibers containing NiS nanoparticles for hybrid supercapacitors." Chemical Engineering Journal 446 (October 2022): 137262. http://dx.doi.org/10.1016/j.cej.2022.137262.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Schug, Christina, Sarah Urnauer, Carsten Jaeckel, et al. "TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer." Endocrine-Related Cancer 26, no. 1 (2019): 89–101. http://dx.doi.org/10.1530/erc-18-0173.

Full text

Abstract:

Based on their excellent tumor-homing capacity, genetically engineered mesenchymal stem cells (MSCs) are under investigation as tumor-selective gene delivery vehicles. Transgenic expression of the sodium iodide symporter (NIS) in genetically engineered MSCs allows noninvasive tracking of MSC homing by imaging of functional NIS expression as well as therapeutic application of 131I. The use of tumor stroma-activated promoters can improve tumor-specific MSC-mediated transgene delivery. The essential role of transforming growth factor B1 (TGFB1) and the SMAD downstream target in the signaling betw

APA, Harvard, Vancouver, ISO, and other styles

22

Dohán, Orsolya, Antonio De la Vieja, Viktoriya Paroder, et al. "The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance." Endocrine Reviews 24, no. 1 (2003): 48–77. http://dx.doi.org/10.1210/er.2001-0029.

Full text

Abstract:

Abstract The Na+/I− symporter (NIS) is an integral plasma membrane glycoprotein that mediates active I− transport into the thyroid follicular cells, the first step in thyroid hormone biosynthesis. NIS-mediated thyroidal I− transport from the bloodstream to the colloid is a vectorial process made possible by the selective targeting of NIS to the basolateral membrane. NIS also mediates active I− transport in other tissues, including salivary glands, gastric mucosa, and lactating mammary gland, in which it translocates I− into the milk for thyroid hormone biosynthesis by the nursing newborn. NIS

APA, Harvard, Vancouver, ISO, and other styles

23

Lawyers Alliance for World Security. "Model NIS export control legislation." Nonproliferation Review 2, no. 3 (1995): 58–63. http://dx.doi.org/10.1080/10736709508436594.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Sommerhäuser, Lea. "NIS-2-Richtlinie erzeugt Umsetzungsdruck." IT-Director 29, no. 10 (2024): 3. http://dx.doi.org/10.1007/s44380-024-0111-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Abd El-Galil, Doaa Mohamed, and Essam Mahmoud. "NIS two-pressure humidity generator." International Journal of Metrology and Quality Engineering 7, no. 3 (2016): 303. http://dx.doi.org/10.1051/ijmqe/2016012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ohara, Keiichiro, Jean-Jacques Vasseur, and Michael Smietana. "NIS-promoted guanylation of amines." Tetrahedron Letters 50, no. 13 (2009): 1463–65. http://dx.doi.org/10.1016/j.tetlet.2009.01.073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Leivo, M. M., J. P. Pekola, and D. V. Averin. "Microrefrigeration by NIS tunnel junctions." Czechoslovak Journal of Physics 46, S5 (1996): 2763–64. http://dx.doi.org/10.1007/bf02570368.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Schmidt, Th, and H. D. Lutz. "Das system NiSCr2S3In2S3." Journal of the Less Common Metals 161, no. 1 (1990): 7–16. http://dx.doi.org/10.1016/0022-5088(90)90308-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Mccabe, C. "The pathophysiology of NIS function." Annales d'Endocrinologie 81, no. 4 (2020): 131. http://dx.doi.org/10.1016/j.ando.2020.07.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Smoła, G., A. Poczekajło, and Z. Grzesik. "Reduction Kinetics Of NiS Sulphide." Archives of Metallurgy and Materials 60, no. 2 (2015): 981–83. http://dx.doi.org/10.1515/amm-2015-0245.

Full text

Abstract:

Abstract Reduction mechanism and kinetics of NiS nickel sulphide obtained during the process of nickel sulphidation, have been studied as a function of temperature (723-873 K). It has been found that the reduction process follows linear kinetics with activation energy of 103 kJ/mol. It is important to note that during nickel sulphidation and after the reduction of nickel sulphide, the product sample shows highly developed surface, creating thus the potential possibilities to be applied in heterogeneous catalysis.

APA, Harvard, Vancouver, ISO, and other styles

31

Rexer, H. "Nichtinterventionelle Studie (NiS) bei Prostatakarzinom." Der Onkologe 18, no. 2 (2012): 161–62. http://dx.doi.org/10.1007/s00761-011-2198-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Spitzweg, C. "Der Natrium-Jodid-Symporter (NIS)." Der Internist 44, no. 4 (2003): 396–411. http://dx.doi.org/10.1007/s00108-003-0877-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Hanum, Aditya, Bayu Azani, Eko Purnomo, and Rifqi Aulia Zaim. "PERANCANGAN KEMASAN RAKIK MAK NIS." Gorga : Jurnal Seni Rupa 11, no. 2 (2022): 379. http://dx.doi.org/10.24114/gr.v11i2.38317.

Full text

Abstract:

Development regional specialties is now increasingly rapid and has a lot of diversity regional specialties, one of which is a snack that is processed in Solok, Gunung Talang District, this snack called rakik. One of the MSMEs that produce this type of food is the UP3HP Farmer Group LEMBANG JAO MANDIRI, Solok which called Rakik Mak Nis. Packaging is container that can help prevent or reduce damage to a product from friction, impact, load and vibration during distribution. Packaging also serves as an identity of a brand. Packaging one of the regulations to be able to place products sold in moder

APA, Harvard, Vancouver, ISO, and other styles

34

Krassnitzer, Michael. "Eine Mammutaufgabe namens NIS-2." Das österreichische Gesundheitswesen ÖKZ 64, no. 12 (2023): 56–57. http://dx.doi.org/10.1007/s43830-023-0414-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Rawal, Sapna, Gabriel J. E. Rinkel, Jiming Fang, et al. "External Validation and Modification of Nationwide Inpatient Sample Subarachnoid Hemorrhage Severity Score." Neurosurgery 89, no. 4 (2021): 591–96. http://dx.doi.org/10.1093/neuros/nyab237.

Full text

Abstract:

Abstract BACKGROUND The Nationwide Inpatient Sample Subarachnoid Hemorrhage (SAH) Severity Score (NIS-SSS) was developed as a measure of SAH severity for use in administrative databases. The NIS-SSS consists of International Classification of Diseases Ninth Revision (ICD-9) diagnostic and procedure codes derived from the SAH inpatient course and has been validated against the Hunt-Hess score (HH). OBJECTIVE To externally validate both the NIS-SSS and a modified version of the NIS-SSS (m-NIS-SSS) consisting of codes present only on admission, against the HH in a Canadian province-wide registry

APA, Harvard, Vancouver, ISO, and other styles

36

Hanieh, Patrizia Nadia, Sara Consalvi, Jacopo Forte, et al. "Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment." Pharmaceutics 14, no. 3 (2022): 610. http://dx.doi.org/10.3390/pharmaceutics14030610.

Full text

Abstract:

Tuberculosis remains one of the world’s deadliest infectious diseases, accounting for nearly 1.3 million deaths every year. Tuberculosis treatment is challenging because of the toxicity, decreased bioavailability at the target site of the conventional drugs and, most importantly, low adherence of patients; this leads to drug resistance. Here, we describe the development of suitable nanocarriers with specific physicochemical properties to efficiently deliver two potent antimycobacterial compounds. We prepared nanoemulsions and niosomes formulations and loaded them with two different MmpL3 inhib

APA, Harvard, Vancouver, ISO, and other styles

37

Lizano, Enric, Josep Grima, and M. Dolors Pujol. "Efficient Halogenation of 2-Aminopyrazine." Synlett 30, no. 17 (2019): 2000–2003. http://dx.doi.org/10.1055/s-0039-1690183.

Full text

Abstract:

2-Aminopyrazine was halogenated with NIS, NCS, and NBS under different reaction conditions. Chlorination and bromination were achieved with good yields by using acetonitrile as the solvent. However, iodination was only obtained in poor yields. Undoubtedly, the best conditions for both mono- and dihalogenation were the use of NBS, acetonitrile, and microwave assistance for short periods. 3,5-Dibromo-2-aminopyrazine is an excellent functionalized starting material for the synthesis of nitrogen heterocycles.

APA, Harvard, Vancouver, ISO, and other styles

38

Wei, Chengzhen, Cheng Cheng, Yanyan Cheng та ін. "Comparison of NiS2 and α-NiS hollow spheres for supercapacitors, non-enzymatic glucose sensors and water treatment". Dalton Transactions 44, № 39 (2015): 17278–85. http://dx.doi.org/10.1039/c5dt02724a.

Full text

Abstract:

NiS<sub>2</sub> and α-NiS hollow spheres are prepared via a template-free method. When NiS<sub>2</sub> and α-NiS hollow spheres were evaluated for supercapacitors, glucose sensors and water treatment, it was found that the hollow α-NiS spheres exhibited better performance than the NiS<sub>2</sub>.

APA, Harvard, Vancouver, ISO, and other styles

39

Dubinina, Inessa Ivanovna, Tatiana Vladimirovna Karapysh, and Nina Fedorovna Nosova. "Efficacy of combined treatment of distal polyneuropathy in patients with type 2 diabetes mellitus and concomitant primaryhypothyroidism." Diabetes mellitus 14, no. 3 (2011): 76–79. http://dx.doi.org/10.14341/2072-0351-6228.

Full text

Abstract:

Aim. To study changes of metabolic parameters and neurologic manifestations in patients with type 2 diabetes mellitus and concomitant primaryhypothyroidism under effect of combined therapy. Materials and methods. 62 patients with distal neuropathy (DN) including 16 with DM2 and primary hypothyroidism (PHT) (group 1), 32 DM2patients without thyroid pathology (group 2), and 15 patients with PHT without DM (group 3). The patients were matched for age and durationof all above diseases. They were treated by alpha lipoic acid-based drugs: thioctacid, thiogamma, berlithion, octolipen (600 U/d i/v), v

APA, Harvard, Vancouver, ISO, and other styles

40

Guan, Yuhao, Kexie Hu, Nan Su, Gaohe Zhang, Yujia Han, and Minrong An. "Review of NiS-Based Electrode Nanomaterials for Supercapacitors." Nanomaterials 13, no. 6 (2023): 979. http://dx.doi.org/10.3390/nano13060979.

Full text

Abstract:

As a new type of energy storage device, supercapacitors have the advantages of high-power densities, high safety factors, and low maintenance costs, so they have attracted widespread attention among researchers. However, a major problem with supercapacitors is that their energy densities are not high enough, which limits their application. Therefore, it is crucial to expand the application scenarios of supercapacitors to increase their energy density as much as possible without diminishing their advantages. The classification and working principles of supercapacitors are introduced in this pap

APA, Harvard, Vancouver, ISO, and other styles

41

Washington, Chad W., Colin P. Derdeyn, Ralph G. Dacey, Rajat Dhar, and Gregory J. Zipfel. "Analysis of subarachnoid hemorrhage using the Nationwide Inpatient Sample: the NIS-SAH Severity Score and Outcome Measure." Journal of Neurosurgery 121, no. 2 (2014): 482–89. http://dx.doi.org/10.3171/2014.4.jns131100.

Full text

Abstract:

Object Studies using the Nationwide Inpatient Sample (NIS), a large ICD-9–based (International Classification of Diseases, Ninth Revision) administrative database, to analyze aneurysmal subarachnoid hemorrhage (SAH) have been limited by an inability to control for SAH severity and the use of unverified outcome measures. To address these limitations, the authors developed and validated a surrogate marker for SAH severity, the NIS-SAH Severity Score (NIS-SSS; akin to Hunt and Hess [HH] grade), and a dichotomous measure of SAH outcome, the NIS-SAH Outcome Measure (NIS-SOM; akin to modified Rankin

APA, Harvard, Vancouver, ISO, and other styles

42

Leyva, Alfonso, Paola Bisignano, Silvia Ravera, et al. "Deep Learning Insights on Na+/I− Symporter (NIS) transport cycle." Structural Dynamics 12, no. 2_Supplement (2025): A413. https://doi.org/10.1063/4.0000719.

Full text

Abstract:

We used cryoEM to determine the structures of apo-NIS and NIS with I− and an oxyanion (ReO4−) bound to it (Fig. 1a) [1]. All apo- and holo-structures showed a NIS molecule in an occluded conformation, poised to open up toward the intracellular medium. The previous lack of information about other conformations NIS adopts in the course of its transport cycle, particularly its outwardly open conformation (Fig. 1b), severely limited our understanding of the NIS transport cycle. To fill this gap in our knowledge, we carried out molecular dynamics simulations of NIS under close-to-physiological cond

APA, Harvard, Vancouver, ISO, and other styles

43

Oberdorfer, Peninnah, Natthida Pongwilairat, and Charles H. Washington. "Nosocomial Infections among Pediatric Patients with Neoplastic Diseases." International Journal of Pediatrics 2009 (2009): 1–5. http://dx.doi.org/10.1155/2009/721320.

Full text

Abstract:

Background. Pediatric patients with neoplastic diseases are more likely to develop nosocomial infections (NIs). NIs may prolong their hospital stay, and increase morbidity and mortality.Objectives. The objectives of this study were to determine: (1) the incidence of NIs, (2) sites of NIs, (3) causal organisms, and (4) outcomes of NIs among pediatric patients with neoplastic diseases.Methods. This study was a prospective cohort study of pediatric patients with neoplastic diseases who were admitted to the Chiang Mai University Hospital, Thailand.Results. A total of 707 pediatric patients with ne

APA, Harvard, Vancouver, ISO, and other styles

44

De la Vieja, Antonio, Orsolya Dohan, Orlie Levy, and Nancy Carrasco. "Molecular Analysis of the Sodium/Iodide Symporter: Impact on Thyroid and Extrathyroid Pathophysiology." Physiological Reviews 80, no. 3 (2000): 1083–105. http://dx.doi.org/10.1152/physrev.2000.80.3.1083.

Full text

Abstract:

The Na+/I−symporter (NIS) is an intrinsic membrane protein that mediates the active transport of iodide into the thyroid and other tissues, such as salivary glands, gastric mucosa, and lactating mammary gland. NIS plays key roles in thyroid pathophysiology as the route by which iodide reaches the gland for thyroid hormone biosynthesis and as a means for diagnostic scintigraphic imaging and for radioiodide therapy in hyperthyroidism and thyroid cancer. The molecular characterization of NIS started with the 1996 isolation of a cDNA encoding rat NIS and has since continued at a rapid pace. Anti-N

APA, Harvard, Vancouver, ISO, and other styles

45

Liu, Yu-Yu, Xiaoli Zhang, Matthew D. Ringel, and Sissy M. Jhiang. "Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells." Endocrine-Related Cancer 19, no. 3 (2012): 291–304. http://dx.doi.org/10.1530/erc-11-0288.

Full text

Abstract:

The selective increase of Na+/I−symporter (NIS)-mediated active iodide uptake in thyroid cells allows the use of radioiodine I131for diagnosis and targeted treatment of thyroid cancers. However, NIS-mediated radioiodine accumulation is often reduced in thyroid cancers due to decreased NIS expression/function. As PI3K signaling is overactivated in many thyroid tumors, we investigated the effects of inhibitors for PI3K, Akt, or mTORC1 as well as their interplay on NIS modulation in thyroid cells under chronic TSH stimulation. PI3K inhibition by LY294002 increased NIS-mediated radioiodide uptake

APA, Harvard, Vancouver, ISO, and other styles

46

Quigley, Denise D., and Zachary Predmore. "Parents Have More to Say: Comments From the Child HCAHPS Single Question Versus a Narrative Item Set." Hospital Pediatrics 13, no. 4 (2023): 345–56. http://dx.doi.org/10.1542/hpeds.2022-007046.

Full text

Abstract:

BACKGROUND AND OBJECTIVES Narrative comments from the Child Hospital Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey from a single open-ended question are specific enough to make improvements (ie, actionable). A multiitem set might yield more insights. We compare comments from the single-item Child Hospital CAHPS and the 6-item beta version Narrative Item Set (NIS). METHODS The Child HCAHPS NIS was piloted 2021 to 2022 at an urban children’s hospital that fielded the Child HCAHPS survey since 2017. We analyzed 382 NIS comments (n = 77 parents and guardians) and compared

APA, Harvard, Vancouver, ISO, and other styles

47

Carlin, Sean, Robert J. Mairs, Phil Welsh, and Michael R. Zalutsky. "Sodium-iodide symporter (NIS)-mediated accumulation of [211At]astatide in NIS-transfected human cancer cells." Nuclear Medicine and Biology 29, no. 7 (2002): 729–39. http://dx.doi.org/10.1016/s0969-8051(02)00332-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Idris, Nurul Hayati, Md Mokhlesur Rahman, Shu-Lei Chou, Jia-Zhao Wang, David Wexler та Hua-Kun Liu. "Rapid synthesis of binary α-NiS–β-NiS by microwave autoclave for rechargeable lithium batteries". Electrochimica Acta 58 (грудень 2011): 456–62. http://dx.doi.org/10.1016/j.electacta.2011.09.066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Li, Huika, Kerry Richard, Brett McKinnon, and Robin H. Mortimer. "Effect of Iodide on Human Choriogonadotropin, Sodium-Iodide Symporter Expression, and Iodide Uptake in BeWo Choriocarcinoma Cells." Journal of Clinical Endocrinology & Metabolism 92, no. 10 (2007): 4046–51. http://dx.doi.org/10.1210/jc.2006-2358.

Full text

Abstract:

Abstract Context: Active placental transport of maternal iodide by the thyroidal sodium iodide symporter (NIS) provides an essential substrate for fetal thyroid hormone synthesis. NIS is expressed in trophoblast and is regulated by human choriogonadotropin (hCG). In thyroid, iodide down-regulates expression of several genes including NIS. Placentas of iodine-deficient rats demonstrate up-regulation of NIS mRNA, suggesting a role for iodide in regulating placental NIS. Objectives and Methods: The objectives were to examine effects of iodide on expression of NIS and hCG in BeWo choriocarcinoma c

APA, Harvard, Vancouver, ISO, and other styles

50

Schmitz, G., L. Füzesi, J. Struck, et al. "Expression of the sodium iodide symporter in differentiated thyroid cancer." Nuklearmedizin 44, no. 03 (2005): 86–96. http://dx.doi.org/10.1055/s-0038-1625711.

Full text

Abstract:

Summary Aim: Molecular analysis of the expression of the sodium iodide symporter (NIS) in 32 patients with differentiated thyroid cancer (DTC) and correlation with scintigraphic findings (131I,123I) in 19 (59.4%) of them. Patients, methods: NIS expression of 27 primary tumours, 13 lymphnodes and 18 distant metastases was determined by immunostaining using a murine monoclonal anti-NIS-antibody. NIS expression and radionuclide uptake of metastases were analysed by a semiquantitative visual score. Patients were divided into two subgroups: Group 1 (n = 8 patients): indirect correlation of radioiod

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!